These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35246495)

  • 21. Differential antigenic requirements by diverse MR1-restricted T cells.
    Seneviratna R; Redmond SJ; McWilliam HE; Reantragoon R; Villadangos JA; McCluskey J; Godfrey DI; Gherardin NA
    Immunol Cell Biol; 2022 Feb; 100(2):112-126. PubMed ID: 34940995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria.
    Suliman S; Murphy M; Musvosvi M; Gela A; Meermeier EW; Geldenhuys H; Hopley C; Toefy A; Bilek N; Veldsman A; Hanekom WA; Johnson JL; Boom WH; Obermoser G; Huang H; Hatherill M; Lewinsohn DM; Nemes E; Scriba TJ
    J Immunol; 2019 Dec; 203(11):2917-2927. PubMed ID: 31611259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection, Expansion, and Isolation of Human MAIT Cells.
    Liu Y; Wang W; Wu X; Weng X
    Methods Mol Biol; 2020; 2111():285-293. PubMed ID: 31933215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
    Lepore M; Lewinsohn DA; Lewinsohn DM
    Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses.
    Chancellor A; Alan Simmons R; Khanolkar RC; Nosi V; Beshirova A; Berloffa G; Colombo R; Karuppiah V; Pentier JM; Tubb V; Ghadbane H; Suckling RJ; Page K; Crean RM; Vacchini A; De Gregorio C; Schaefer V; Constantin D; Gligoris T; Lloyd A; Hock M; Srikannathasan V; Robinson RA; Besra GS; van der Kamp MW; Mori L; Calogero R; Cole DK; De Libero G; Lepore M
    J Exp Med; 2023 Sep; 220(9):. PubMed ID: 37382893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple Isomers of Photolumazine V Bind MR1 and Differentially Activate MAIT Cells.
    Krawic JR; Ladd NA; Cansler M; McMurtrey C; Devereaux J; Worley A; Ahmed T; Froyd C; Kulicke CA; Swarbrick G; Nilsen A; Lewinsohn DM; Adams EJ; Hildebrand W
    J Immunol; 2024 Mar; 212(6):933-940. PubMed ID: 38275935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of the antigen-presenting molecule MR1 by a Vδ3
    Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor.
    Reantragoon R; Kjer-Nielsen L; Patel O; Chen Z; Illing PT; Bhati M; Kostenko L; Bharadwaj M; Meehan B; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2012 Apr; 209(4):761-74. PubMed ID: 22412157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the TCRβ repertoire of peripheral MR1-restricted MAIT cells in psoriasis vulgaris patients.
    Jirouš Drulak M; Grgić Z; Plužarić V; Šola M; Opačak-Bernardi T; Viljetić B; Glavaš K; Tolušić-Levak M; Periša V; Mihalj M; Štefanić M; Tokić S
    Sci Rep; 2023 Nov; 13(1):20990. PubMed ID: 38017021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological evaluation and molecular modelling of new potent clickable analogues of 5-OP-RU for their use as chemical probes for the study of MAIT cell biology.
    Yvorra T; Steinmetz A; Retailleau P; Lantz O; Schmidt F
    Eur J Med Chem; 2021 Feb; 211():113066. PubMed ID: 33341648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.
    Ruf B; Catania VV; Wabitsch S; Ma C; Diggs LP; Zhang Q; Heinrich B; Subramanyam V; Cui LL; Pouzolles M; Evans CN; Chari R; Sakai S; Oh S; Barry CE; Barber DL; Greten TF
    Cancer Immunol Res; 2021 Sep; 9(9):1024-1034. PubMed ID: 34193462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.
    López-Sagaseta J; Dulberger CL; Crooks JE; Parks CD; Luoma AM; McFedries A; Van Rhijn I; Saghatelian A; Adams EJ
    Proc Natl Acad Sci U S A; 2013 May; 110(19):E1771-8. PubMed ID: 23613577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview on the identification of MAIT cell antigens.
    Kjer-Nielsen L; Corbett AJ; Chen Z; Liu L; Mak JY; Godfrey DI; Rossjohn J; Fairlie DP; McCluskey J; Eckle SB
    Immunol Cell Biol; 2018 Jul; 96(6):573-587. PubMed ID: 29656544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU).
    Li K; Vorkas CK; Chaudhry A; Bell DL; Willis RA; Rudensky A; Altman JD; Glickman MS; Aubé J
    PLoS One; 2018; 13(2):e0191837. PubMed ID: 29401462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.
    Kawachi I; Maldonado J; Strader C; Gilfillan S
    J Immunol; 2006 Feb; 176(3):1618-27. PubMed ID: 16424191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical Modulators of Mucosal Associated Invariant T Cells.
    Mak JYW; Liu L; Fairlie DP
    Acc Chem Res; 2021 Sep; 54(17):3462-3475. PubMed ID: 34415738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation.
    Tastan C; Karhan E; Zhou W; Fleming E; Voigt AY; Yao X; Wang L; Horne M; Placek L; Kozhaya L; Oh J; Unutmaz D
    Mucosal Immunol; 2018 Nov; 11(6):1591-1605. PubMed ID: 30115998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human liver CD8
    Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
    J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRAV1-2
    Wong EB; Gold MC; Meermeier EW; Xulu BZ; Khuzwayo S; Sullivan ZA; Mahyari E; Rogers Z; Kløverpris H; Sharma PK; Worley AH; Lalloo U; Baijnath P; Ambaram A; Naidoo L; Suleman M; Madansein R; McLaren JE; Ladell K; Miners KL; Price DA; Behar SM; Nielsen M; Kasprowicz VO; Leslie A; Bishai WR; Ndung'u T; Lewinsohn DM
    Commun Biol; 2019; 2():203. PubMed ID: 31231693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.